Information For Authors

Our dynamic Author Benefits Program provides you with end-to-end benefits that ensure your hard work pays off and your published manuscript gets the attention it deserves not just upon publication, but permanently.


Games for Health Journal: Research, Development, and Clinical Applications publishes quantitative scientific articles in a wide range of health areas that are addressed in health games, such as physical activity, healthy lifestyle, disease prevention and self-management, adherence to treatment plans, mental and cognitive health, and clinical training and delivery of care. Also of interest are articles that test and advance theories and research methods relevant to the field, and outcomes studies that demonstrate how and why a health game was effective with a specific target population. In addition to peer-reviewed scientific articles, the journal will include news, product reviews, event announcements, roundtable discussions and opinion pieces.

The Journal explores the development, applications, use and results of fixed and portable games and game-related devices and activities to directly or indirectly improve physical and mental health and well-being. Examples include simulation and training of health providers for new therapies; games and related devices to improve physical fitness, reduce obesity and overcome injuries; and behavior modification training for loved ones suffering from battlefield post-traumatic stress disorder.

All manuscripts must be submitted online at

Please read all the instructions to authors before submitting.


All manuscripts should be prepared in Word.  Do not upload PDFs of any text files.

Original Research Papers: The title page should include the authors' names and affiliations, the source of a work or study (if any), and a running title of about 45 characters. Please indicate the author to whom correspondence should be sent when you submit. The abstract should be no more than 250 words and should be self-explanatory without reference to the text. Abstracts should be structured and contain separate sections as follows: Objective, Materials and Methods, Results, and Conclusion. Perspective papers should follow this format: Abstract (unstructured), Introduction, Materials and Methods, Results, Discussion, Acknowledgments, Author Disclosure, and References. The body of the MS should not exceed 3,000 words. At the end of the manuscript, give the name and address of the individual to whom correspondence should be directed.

Brief Communications: An abstract of 300 words should outline the purpose, methodology and results of the communication. The format for the body of the manuscript may vary depending upon the nature of the report but may not exceed 1,000 words. References should be included.

Reviews: An abstract of 250 words should state the subject of the review and its importance. The abstract should summarize the most important points of the review. The body of the manuscript should take on headings appropriate for the topic (for example: Introduction, Technology Issues, Regulatory Issues, Clinical Studies). The body of the text should not exceed 3,000 words.

Other Communications: The editors welcome letters concerning items published in the Journal. Book reviews and potential news items are also welcome.

Please adhere to the following instructions to avoid delays in processing.


Use Arabic numerals to number tables. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences. Provide titles for all tables. Define all acronyms in table footnotes. All other types of table footnotes should be designated using superscript letters, not symbols.

When naming your figure files, please label them with the author's last name, followed by the figure number. Ex: SmithFig1.tif. Label figures and tables inside the files in addition to naming the file with the figure or table number. (ie: When figures or table files are opened, the figure or table number should appear inside the file.)

Electronic submission of art MUST follow these guidelines:

  1. Do not include any illustrations as part of your text file.
  2. Do not prepare any figures in Word as they are not workable. 
  3. Line illustrations must be submitted at 900 DPI.
  4. Halftones and color photos should be submitted at 300 DPI. 
  5. Please submit only TIFF or EPS files.
  6. Color art must be saved as CYMK not RGB. If RGB files are submitted, the files will be converted to CYMK, and some color variation may occur.
  7. PowerPoint or Excel files cannot be uploaded.


Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.”

All authors must disclose any associations that pose real or perceived conflicts of interest in connection with the manuscript. Authors should also disclose any financial interests that they may have in the company supporting the work. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are perceived, potential, or actual be disclosed. This information will remain confidential while the paper is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."


Patients and Study Participants
All manuscripts must comply with the privacy and confidentiality requirements outlined on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals website. For more information, visit

When articles include reports of studies on human subjects, state in the Methods section that an appropriate institutional review board or ethics committee approved the study. Authors who do not have formal ethics review committees should follow the principles of the Declaration of Helsinki. In the Methods section, state that informed consent was obtained from subjects (specify written or verbal).

The principal author must state that if animals were used experimentally, permission was obtained from the appropriate committee(s), and that the animals were treated humanely and the standards conformed to those of current ethical animal research practices.

In addition, text and photographs should not reveal any identifying information unless it is essential for scientific purposes (in which case, consent should be obtained). Masking the subjects’ eyes in photographs is often insufficient to protect their identity.


When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

*This portion of Games for Health Journal’s Instructions for Authors has been quoted directly from the Uniform Requirements for Manuscripts Submitted to Biomedical Journals website. For more information, visit 




Study Design and Ethics

Documented review and approval from a formally constituted review board (Institutional Review Board or Ethics committee) should be required for all studies involving people, medical records, and human tissues. For those investigators who do not have access to formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. If the study is judged exempt from review, a statement from the committee should be required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and a sentence declaring adherence should be included in the acknowledgment section of the manuscript.

Animal experiments should require full compliance with local, national, ethical, and regulatory principles, and local licensing arrangements.

Definitions of Scientific Misconduct

Mary Ann Liebert, Inc., publishers generally follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).

Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:

  • Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.

  •  Authorship Disputes: Deliberate misrepresentation of a scientist’s contribution to the published work, or purposefully omitting the contributions of a scientist.

  • Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.

  • Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.

  • Material failure to comply with legislative and regulatory requirements affecting research:
    Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.

  • Conflict of Interest:  Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.

  • Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.

  • Plagiarism: Purposely claiming another’s work or idea as your own constitutes misconduct and/or fraud.

  • Simultaneous Submission:  Submitting a paper to more than one publication at the same time constitutes misconduct.

Responding to Allegations of Possible Misconduct

The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation.  As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.

When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper.  In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.

Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.

If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record.  If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.

All allegations will be kept confidential.


Please upload individual files of all manuscript material — do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.



A complete list of all cited references must be presented at the end of the manuscript. All supplied references must be cited in text as superscripted numbers in the order of citation, outside any punctuation, and without parentheses.


Parisod H, Pakarinen A, Kauhanen L, et al.  Promoting children’s health with digital games:  a review of reviews.  Games Health J 2014; 3:145-156.



Beale IL. Video Games for Health Journal: Principles and Strategies for Design and Evaluation (Public Health in the 21st Century). Hauppauge NY; Nova Science Publishers, Inc.; 2011.


If it is necessary to cite an abstract, this should be so designated. Authors are responsible for the accuracy of the reference and are reminded that inaccurate references are highly frustrating to the reader, the cited author, and indexing services. Abbreviations of journal titles should follow Medline


Reference citations are not permitted in the abstract of any paper.



Follow the Uniform Guidelines for manuscripts submitted to biomedical journals (Ann Intern Med 1988; 108:258-265). Papers will be edited to conform to the individual style of Games for Health Journal.


The author must obtain permission to reproduce figures, tables, and text from previously published material, even if it is the author's own work. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned. An appropriate credit line should be included in the figure legend or table footnote, and full publication information should be included in the reference list. Written permission must be obtained from the author of any unpublished material cited from other institutions and should accompany the manuscript. 


Institutional affiliations, as indicated on the title page, should include all corporate affiliations and all funding sources that support the work.


Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

Games for Health Journal publishes 6 issues annually by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; fax: (914) 740–2101; online:

Liebert Open Access

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option

Does your research funder have an open access mandate or would you like to expand the dissemination of your research?

The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.

The benefits of Liebert Open Access include:

- High visibility; open access articles are freely available online upon publication

- You retain copyright with the open access license allowing broad dissemination of your research

- You can freely share your article in repositories and research networks without restrictions

- Easy compliance with open access mandates

- Rigorous editorial and peer-review

- Targeted email announcement featuring a direct link to article

Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.

Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.

At this time we allow authors to choose between the CC-BY or CC-BY-NonCommercial license. A limited number of journals offer NonCommercial licenses exclusively.

Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email

Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form.  You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.

Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


Valuable benefits of OA available for download.

Browse journals in the Liebert Open Access portfolio:

NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

Publishing in Subscription Journals

By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.

Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.

The final published article (version of record) can never be archived in a repository, preprint server, or research network.


Publishing Open Access

Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email or visit Liebert Open Access for more information.

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Upcoming Events

Oct 17 - Oct 19, 2018